Lentilactobacillus hilgardii H-50 strongly inhibits lipopolysaccharide-induced inflammatory responses in mouse splenocytes via its specific surface layer proteins

J Appl Microbiol. 2023 Mar 1;134(3):lxad021. doi: 10.1093/jambio/lxad021.

Abstract

Aims: Certain lactic acid bacteria (LAB) are known to have anti-inflammatory effects; however, hiochi bacteria, which are taxonomically classified as LAB and known to spoil a traditional Japanese alcoholic beverage, have not been studied in the same context. The aim of this study is to investigate the anti-inflammatory effects of hiochi bacteria strains and the underlying mechanisms.

Methods and results: We screened 45 strains of hiochi bacteria for anti-inflammatory effects and found that Lentilactobacillus hilgardii H-50 strongly inhibits lipopolysaccharide (LPS)-induced secretion of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 in mouse splenocytes. This inhibition is attributed to its specific surface layer proteins (SLPs), which directly bind to LPS.

Conclusions: The L. hilgardii H-50 strain exerts anti-inflammatory effects through its SLPs.

Keywords: Lentilactobacillus hilgardii; Lactic acid bacteria; Lipopolysaccharide; anti-inflammatory properties; surface layer protein.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Lipopolysaccharides* / pharmacology
  • Mice
  • Spleen* / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Lipopolysaccharides
  • S-layer proteins
  • Tumor Necrosis Factor-alpha
  • Anti-Inflammatory Agents

Supplementary concepts

  • Lactobacillus hilgardii